BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21333629)

  • 1. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
    Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
    Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a real-time fluorescence monitoring system for high-throughput screening for prolyl isomerase inhibitors.
    Mori T; Itami S; Yanagi T; Tatara Y; Takamiya M; Uchida T
    J Biomol Screen; 2009 Apr; 14(4):419-24. PubMed ID: 19403925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptidyl-prolyl isomerase inhibitors.
    Wang XJ; Etzkorn FA
    Biopolymers; 2006; 84(2):125-46. PubMed ID: 16302169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
    Ieda N; Itoh K; Inoue Y; Izumiya Y; Kawaguchi M; Miyata N; Nakagawa H
    Bioorg Med Chem Lett; 2019 Feb; 29(3):353-356. PubMed ID: 30585173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-throughput screen for inhibitors of the prolyl isomerase, Pin1, identifies a seaweed polyphenol that reduces adipose cell differentiation.
    Mori T; Hidaka M; Ikuji H; Yoshizawa I; Toyohara H; Okuda T; Uchida C; Asano T; Yotsu-Yamashita M; Uchida T
    Biosci Biotechnol Biochem; 2014; 78(5):832-8. PubMed ID: 25035986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of enzyme activities and mRNA levels of peptidyl prolyl cis/trans isomerases in various organs of wild type and Pin1-/- mice.
    Fanghänel J; Akiyama H; Uchida C; Uchida T
    FEBS Lett; 2006 May; 580(13):3237-45. PubMed ID: 16697379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-guided design of alpha-amino acid-derived Pin1 inhibitors.
    Potter AJ; Ray S; Gueritz L; Nunns CL; Bryant CJ; Scrace SF; Matassova N; Baker L; Dokurno P; Robinson DA; Surgenor AE; Davis B; Murray JB; Richardson CM; Moore JD
    Bioorg Med Chem Lett; 2010 Jan; 20(2):586-90. PubMed ID: 19969456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1.
    Tatara Y; Lin YC; Bamba Y; Mori T; Uchida T
    Biochem Biophys Res Commun; 2009 Jul; 384(3):394-8. PubMed ID: 19422802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1.
    Jiang B; Pei D
    J Med Chem; 2015 Aug; 58(15):6306-12. PubMed ID: 26196061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolyl cis/trans isomerase signalling pathways in cancer.
    Theuerkorn M; Fischer G; Schiene-Fischer C
    Curr Opin Pharmacol; 2011 Aug; 11(4):281-7. PubMed ID: 21497135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Pin1 inhibitory activity of thiazole derivatives.
    Zhao H; Cui G; Jin J; Chen X; Xu B
    Bioorg Med Chem; 2016 Nov; 24(22):5911-5920. PubMed ID: 27692510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries.
    Wildemann D; Erdmann F; Alvarez BH; Stoller G; Zhou XZ; Fanghänel J; Schutkowski M; Lu KP; Fischer G
    J Med Chem; 2006 Apr; 49(7):2147-50. PubMed ID: 16570909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation.
    Uchida T; Takamiya M; Takahashi M; Miyashita H; Ikeda H; Terada T; Matsuo Y; Shirouzu M; Yokoyama S; Fujimori F; Hunter T
    Chem Biol; 2003 Jan; 10(1):15-24. PubMed ID: 12573694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel thiazole-based derivatives as human Pin1 inhibitors.
    Du L; Wang X; Cui G; Xu B
    Bioorg Med Chem; 2021 Jan; 29():115878. PubMed ID: 33246256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design of novel human Pin1 inhibitors (I).
    Guo C; Hou X; Dong L; Dagostino E; Greasley S; Ferre R; Marakovits J; Johnson MC; Matthews D; Mroczkowski B; Parge H; Vanarsdale T; Popoff I; Piraino J; Margosiak S; Thomson J; Los G; Murray BW
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5613-6. PubMed ID: 19729306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Design, synthesis and biological evaluation of novel diaryl ethers bearing a pyrimidine motif as human Pin1 inhibitors].
    Xi YY; Jin J; Sun Y; Chen XG; Song HR; Xu BL
    Yao Xue Xue Bao; 2013 Aug; 48(8):1266-72. PubMed ID: 24187834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prolyl isomerase pin1 in pathogenesis of diseases and remedy for the diseases from natural products.
    Takahashi K; Shimizu T; Kosaka K; Hidaka M; Uchida C; Uchida T
    Curr Drug Targets; 2014; 15(10):973-81. PubMed ID: 25182609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere.
    Wang XJ; Xu B; Mullins AB; Neiler FK; Etzkorn FA
    J Am Chem Soc; 2004 Dec; 126(47):15533-42. PubMed ID: 15563182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological Function of Pin1 in Vivo and Its Inhibitors for Preclinical Study: Early Development, Current Strategies, and Future Directions.
    He S; Li L; Jin R; Lu X
    J Med Chem; 2023 Jul; 66(14):9251-9277. PubMed ID: 37438908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pin1 Modulation in Physiological Status and Neurodegeneration. Any Contribution to the Pathogenesis of Type 3 Diabetes?
    Bianchi M; Manco M
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.